Breaking News Instant updates and real-time market news.

NLNK

NewLink Genetics

$9.00

-1.06 (-10.54%)

13:36
01/08/18
01/08
13:36
01/08/18
13:36

NewLink Genetics sees enrolling majority of Indigo301 trial by end 2018

NewLink Genetics earlier announced Indigo301, the name of its upcoming Phase 3 trial of indoximod plus PD-1 inhibitors for patients with advanced melanoma, and outlined 2018 business priorities to support this trial. In addition, the company updated clinical and financial guidance and provided preliminary unaudited financial information for year-end 2017. To expedite the enrollment of Indigo301, NewLink Genetics has expanded the planned number of trial sites both within and outside of the US and plans several clinical recruitment initiatives to engage with the oncology community with the goal to enroll the majority of patients in 2018. As a result of these clinical planning efforts, NewLink Genetics is accordingly updating its guidance for clinical trials as follows: Enroll the majority of Indigo301 trial by the end of 2018; Phase 2 results for indoximod + PD-1 blockade in advanced melanoma expected in 2018; Phase 2 results for indoximod + gem/nab-paclitaxel in pancreatic cancer expected 1H 2018; Phase 2 randomized AstraZeneca collaboration in pancreatic cancer to initiate 1H 2018. "Entering 2018, we have aligned our business and investments to drive Indigo301 and other high-potential development programs. As we continue to progress, we remain committed to maintaining the strength of our balance sheet in support of our most promising clinical programs," said CFO Jack Henneman. NewLink Genetics ended 2017 with approximately $158M in cash and cash equivalents, the company noted.

  • 25

    Jan

NLNK NewLink Genetics
$9.00

-1.06 (-10.54%)

10/13/17
BOFA
10/13/17
INITIATION
Target $22
BOFA
Buy
NewLink Genetics initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Ying Huang initiated NewLing Genetics with a Buy and $22 price target saying shares are undervalued. The analyst said Newlink is focused on development of indoximod, an IDO pathway inhibitor, which could become a "backbone" therapy for cancer treatment.
10/13/17
10/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Visa (V) and MasterCard (MA) were initiated with an Overweight at Stephens. 2. Acuity Brands (AYI) initiated with a Sector Weight at KeyBanc. 3. Williams-Sonoma (WSM) and RH (RH) were initiated with a Hold at Stifel. 4. Signature Bank (SBNY) assumed with a Neutral at Piper Jaffray. 5. NewLink Genetics (NLNK) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/03/17
STFL
11/03/17
NO CHANGE
Target $25
STFL
Buy
NewLink Genetics price target lowered to $25 from $29 at Stifel
Stifel analyst Stephen Willey trimmed his price target on NewLink Genetics (NLNK) to $25 from $29 to reflect incremental dilution from its recent equity fundraising and forecast for increased operating expenses given that the company will soon initiate its pivotal Phase 3 melanoma trial. The analyst, who expects NewLink shares to remain sensitive to near-term data points on the IDO inhibitor front from Bristol-Myers (BMY) and the partnership of Incyte (INCY) and Merck (MRK), keeps a Buy rating on NewLink shares.
11/30/17
GABE
11/30/17
NO CHANGE
Target $133
GABE
Buy
Incyte a top biotech pick for 2018 at Gabelli
Gabelli analyst Jing He highlighted Incyte as his top biotech pick for 2018 telling investors shares are undervalued and should benefit from the Epa melanoma data readout in first half 2018. The analyst said shares are trading near a 52-week low despite progress in the pipeline and believes competitors Bristol-Myers (BMY) and NewLink's (NLNK) IDO inhibitors are a few years behind Epa in development. Further, as tax reform gains more clarity, He believes M&A oncology deals could pickup and views Incyte as an attractive takeover target. Jing He rates Incyte a Buy with a $133 price target.

TODAY'S FREE FLY STORIES

SNE

Sony

$48.38

-0.22 (-0.45%)

20:47
05/21/18
05/21
20:47
05/21/18
20:47
Hot Stocks
Sony targets operating cash flow of Y2T as part of its mid-range plan »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

BOFI

BofI Holding

$41.97

0.29 (0.70%)

20:40
05/21/18
05/21
20:40
05/21/18
20:40
Downgrade
BofI Holding rating change at Compass Point »

BofI Holding downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 24

    Sep

SNE

Sony

$48.38

-0.22 (-0.45%)

20:32
05/21/18
05/21
20:32
05/21/18
20:32
Hot Stocks
Sony confirms to acquire 60% equity interest in DH Publishing which manages EMI »

Mubadala Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SNE

Sony

$48.38

-0.22 (-0.45%)

20:25
05/21/18
05/21
20:25
05/21/18
20:25
Conference/Events
Sony to hold IR Day 2018 »

Sony IR Day 2018 to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

TJX

TJX

$84.66

-0.15 (-0.18%)

, AZO

AutoZone

$665.68

13.03 (2.00%)

20:25
05/21/18
05/21
20:25
05/21/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

TJX

TJX

$84.66

-0.15 (-0.18%)

AZO

AutoZone

$665.68

13.03 (2.00%)

KSS

Kohl's

$65.47

1.79 (2.81%)

AAP

Advance Auto Parts

$119.18

0.93 (0.79%)

EV

Eaton Vance

$58.05

0.52 (0.90%)

TOL

Toll Brothers

$43.60

0.43 (1.00%)

IGT

International Game

$29.75

-0.655 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 24

    May

  • 24

    May

ADBE

Adobe

$238.00

-0.04 (-0.02%)

19:54
05/21/18
05/21
19:54
05/21/18
19:54
Recommendations
Adobe analyst commentary at JPMorgan »

Adobe adds the missing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

SNE

Sony

$48.38

-0.22 (-0.45%)

19:36
05/21/18
05/21
19:36
05/21/18
19:36
Periodicals
Breaking Periodicals news story on Sony »

Sony to buy out remaining…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

K

Kellogg

$60.77

0.58 (0.96%)

19:28
05/21/18
05/21
19:28
05/21/18
19:28
Conference/Events
Kellogg management to meet with JPMorgan »

Meetings to be held New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

ST

Sensata

$52.58

(0.00%)

19:24
05/21/18
05/21
19:24
05/21/18
19:24
Earnings
Sensata backs FY18 EPS view $3.57-$3.73 following valves business sale »

Consensus $3.66. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

ST

Sensata

$52.58

(0.00%)

19:22
05/21/18
05/21
19:22
05/21/18
19:22
Hot Stocks
Sensata enters $173M deal to sell its valves business to Pacific Industrial Co »

Sensata Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

ELLI

Ellie Mae

$104.16

0.35 (0.34%)

19:20
05/21/18
05/21
19:20
05/21/18
19:20
Conference/Events
Ellie Mae management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 12

    Jun

FB

Facebook

$184.48

1.79 (0.98%)

19:19
05/21/18
05/21
19:19
05/21/18
19:19
Periodicals
U.K. lawmakers seek answers from Facebook CEO on data misuse, Reuters says »

U.K. lawmakers want…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

BA

Boeing

$363.95

12.71 (3.62%)

19:18
05/21/18
05/21
19:18
05/21/18
19:18
Periodicals
Boeing Charleston workers to vote on union representation on May 31, WSJ says »

The U.S. National Labor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ESLOY

Essilor

$0.00

(0.00%)

19:17
05/21/18
05/21
19:17
05/21/18
19:17
Conference/Events
Essilor management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

WIX

Wix.com

$85.45

-3.25 (-3.66%)

, SHOP

Shopify

$144.58

-2.45 (-1.67%)

19:06
05/21/18
05/21
19:06
05/21/18
19:06
Recommendations
Wix.com, Shopify, Adobe analyst commentary at JPMorgan »

After Magento deal, Adobe…

WIX

Wix.com

$85.45

-3.25 (-3.66%)

SHOP

Shopify

$144.58

-2.45 (-1.67%)

ADBE

Adobe

$238.00

-0.04 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 12

    Jun

MU

Micron

$55.48

2.11 (3.95%)

19:05
05/21/18
05/21
19:05
05/21/18
19:05
Conference/Events
Micron management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 22

    May

  • 30

    May

GSM

Ferroglobe

$11.35

0.36 (3.28%)

, CRMT

America's Car-Mart

$54.60

-0.05 (-0.09%)

19:00
05/21/18
05/21
19:00
05/21/18
19:00
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS:…

GSM

Ferroglobe

$11.35

0.36 (3.28%)

CRMT

America's Car-Mart

$54.60

-0.05 (-0.09%)

MU

Micron

$55.48

2.11 (3.95%)

MUFG

Mitsubishi UFJ

$6.45

-0.01 (-0.15%)

AKAM

Akamai

$76.46

1.13 (1.50%)

ADBE

Adobe

$238.00

-0.04 (-0.02%)

PSTG

Pure Storage

$23.60

-0.065 (-0.27%)

NDSN

Nordson

$139.50

4.45 (3.30%)

IGT

International Game

$29.75

-0.655 (-2.15%)

LBY

Libbey

$6.84

-0.27 (-3.80%)

ARDX

Ardelyx

$5.65

-0.15 (-2.59%)

SAIL

SailPoint

$22.43

-0.16 (-0.71%)

CADE

Cadence Bancorp

$29.07

0.01 (0.03%)

TWOU

2U

$95.50

-0.16 (-0.17%)

MYOK

MyoKardia

$48.30

-3.45 (-6.67%)

SHOP

Shopify

$144.58

-2.45 (-1.67%)

AIR

AAR Corp.

$47.70

0.74 (1.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 21

    May

  • 21

    May

  • 21

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 24

    May

  • 30

    May

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 13

    Jun

  • 13

    Jun

  • 26

    Jun

  • 10

    Jul

  • 10

    Sep

  • 24

    Sep

  • 22

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 24

    May

  • 24

    May

AVA

Avista

$52.62

0.07 (0.13%)

18:55
05/21/18
05/21
18:55
05/21/18
18:55
Hot Stocks
CFIUS says no unresolved security concerns over Hydro One-Avista deal »

Hydro One Limited and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEST

Destination Maternity

$2.68

-0.03 (-1.11%)

18:40
05/21/18
05/21
18:40
05/21/18
18:40
Hot Stocks
Investors say Destination Maternity needs 'fresh perspectives' »

Nathan G. Miller and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ARWR

Arrowhead

$9.78

-0.21 (-2.10%)

18:35
05/21/18
05/21
18:35
05/21/18
18:35
Conference/Events
Arrowhead management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

JHX

James Hardie

$17.32

(0.00%)

18:31
05/21/18
05/21
18:31
05/21/18
18:31
Earnings
James Hardie reports FY18 net profit $146.1M vs. $276.5M last year »

Reports FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$90.13

0.88 (0.99%)

18:27
05/21/18
05/21
18:27
05/21/18
18:27
Conference/Events
West Pharmaceutical management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

  • 23

    May

  • 19

    Jun

SSRM

SSR Mining

$10.30

0.02 (0.19%)

18:20
05/21/18
05/21
18:20
05/21/18
18:20
Conference/Events
SSR Mining management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

PDCE

PDC Energy

$65.33

1.57 (2.46%)

18:18
05/21/18
05/21
18:18
05/21/18
18:18
Hot Stocks
PDC Energy Amidon sells 8,045 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

GSM

Ferroglobe

$11.35

0.36 (3.28%)

18:15
05/21/18
05/21
18:15
05/21/18
18:15
Conference/Events
Ferroglobe management to meet with Jefferies »

Meeting to be held in w…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 22

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.